MFDS
- Marketing authorisation holder: HALEON US HOLDINGS
- Status: likely_approved
🇰🇷 Excedrin Extra Strength Pain Reliever in South Korea
Excedrin Extra Strength Pain Reliever (NSAID) regulatory status in South Korea.
Marketing authorisation
Excedrin Extra Strength Pain Reliever in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Excedrin Extra Strength Pain Reliever approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Excedrin Extra Strength Pain Reliever in South Korea?
HALEON US HOLDINGS holds the South Korean marketing authorisation.